Presence of the minor allele of microRNA205 rs3842530 polymorphism increases 18FDG uptake in patients with breast cancer via targeting VEGF

Qu,Shiying; Wang,Tie; Huang,Jingwei

doi:10.3892/mmr.2017.7914

Presence of the minor allele of microRNA205 rs3842530 polymorphism increases 18FDG uptake in patients with breast cancer via targeting VEGF

Authors:
- Shiying Qu
- Tie Wang
- Jingwei Huang
View Affiliations

Affiliations: Department of Nuclear Medicine, Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100020, P.R. China
Published online on: October 27, 2017 https://doi.org/10.3892/mmr.2017.7914
Pages: 636-642

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) are regarded as key regulators of gene expression involved in the pathogenesis of various diseases. Numerous single nucleotide polymorphisms (SNPs) in miRNA genes have been found to be associated with human diseases by affecting the processing process of miRNAs. In the present study, patients with breast cancer underwent a PET scan, and the maximum standard uptake value (SUVmax)/partial volume‑corrected standard uptake value (SUVpvc) were determined in each individual. The samples were collected and genotyped for rs3842530. Statistical analysis was performed to evaluate the difference between the genotype groups. The results demonstrated that miR‑205 downregulated the expression of vascular endothelial growth factor (VEGF) by binding to its 3'untranslated region. The introduction of exogenous miRNA, which mimicked miR‑205, decreased the protein and mRNA expression levels of VEGF and, consistently, the suppression of endogenous miR‑205 resulted in an increase in the expression levels of VEGF. Furthermore, it was found that the expression of mature miR‑205 was markedly reduced by the presence of rs3842530. 18F‑fluorodeoxyglucose (18FDG) metabolism, including SUVmax and SUVpvc, are important parameters of PET, and dysregulation of the expression of VEGF has been reported to be associated with an altered 18FDG metabolism. In the present study, it was found that the presence of minor allele rs3842530 was correlated with increased SUVmax and SUVpvc, which may have been mediated by release of the physiologically inhibited expression of VEGF. Therefore, VEGF was a direct target of miR‑205, and the presence of rs3842530 compromised the expression of miR‑205, suggesting it is a promising biomarker for the metabolism of 18FDG.

View Figures

View References

1	Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K and Uno K: Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 to 3 cm in size. Ann Thorac Surg. 79:984–989. 2005. View Article : Google Scholar : PubMed/NCBI
2	Cronin P, Dwamena BA, Kelly AM and Carlos RC: Solitary pulmonary nodules: Meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology. 246:772–782. 2008. View Article : Google Scholar : PubMed/NCBI
3	Wahidi MM, Govert JA, Goudar RK, Gould MK and McCrory DC: American College of Chest Physicians: Evidence for the treatment of patients with pulmonary nodules: When is it breast cancer? ACCP evidence-based clinical practice guidelines. Chest. 132 Suppl 3:S94–S107. 2007. View Article : Google Scholar
4	Wong N and Wang X: miRDB: An online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43:(Database Issue). D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
5	Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF and Hoekstra OS: Clinical prediction model to characterize pulmonary nodules: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest. 128:2490–2496. 2005. View Article : Google Scholar : PubMed/NCBI
6	Kim SH, Cho YR, Kim HJ, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, et al: Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway. Blood. 120:4892–4902. 2012. View Article : Google Scholar : PubMed/NCBI
7	Yanokura M, Banno K, Kobayashi Y, Kisu I, Ueki A, Ono A, Masuda K, Nomura H, Hirasawa A, Susumu N and Aoki D: MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett. 1:935–940. 2010.PubMed/NCBI
8	Engels BM and Hutvagner G: Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 25:6163–6169. 2006. View Article : Google Scholar : PubMed/NCBI
9	Philippe L, Alsaleh G, Bahram S, Pfeffer S and Georgel P: The miR-17~92 cluster: A key player in the control of inflammation during rheumatoid arthritis. Front Immunol. 4:702013. View Article : Google Scholar : PubMed/NCBI
10	Dylla L, Moore C and Jedlicka P: MicroRNAs in Ewing sarcoma. Front Oncol. 3:652013. View Article : Google Scholar : PubMed/NCBI
11	Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B and Pilger E: A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 37:443–448. 2000. View Article : Google Scholar : PubMed/NCBI
12	Wolf G, Aigner RM, Schaffler G, Langsenlehner U, Renner W, Samonigg H, Yazdani-Biuki B and Krippl P: The 936C> T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake. Breast Cancer Res Treat. 88:205–208. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bae SJ, Kim JW, Kang H, Hwang SG, Oh D and Kim NK: Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 28:1271–1276. 2008.PubMed/NCBI
14	Li J, Li L, Li Z, Gong G, Chen P, Liu H, Wang J, Liu Y and Wu X: The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. Gynecol Oncol. 137:125–133. 2015. View Article : Google Scholar : PubMed/NCBI
15	Wang L, Shan M, Liu Y, Yang F, Qi H, Zhou L, Qiu L and Li Y: miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma Mg-63 cells by targeting VEGFA. Onco Targets Ther. 16:2635–2642. 2015.
16	Leng S, Bernauer AM, Zhai R, Tellez CS, Su L, Burki EA, Picchi MA, Stidley CA, Crowell RE, Christiani DC and Belinsky SA: Discovery of common SNPs in the miR-205/200 family-regulated epithelial to mesenchymal transition pathway and their association with risk for non-small cell lung cancer. Int J Mol Epidemiol Genet. 2:145–155. 2011.PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009. View Article : Google Scholar : PubMed/NCBI
19	Schmittgen TD: Regulation of microRNA processing in development, differentiation and cancer. J Cell Mol Medicine. 12:1811–1819. 2008. View Article : Google Scholar
20	Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, et al: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 26:462–469. 2008. View Article : Google Scholar : PubMed/NCBI
21	Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009. View Article : Google Scholar : PubMed/NCBI
22	Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et al: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival. Clin Cancer Res. 15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
23	Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K and Itoh H: Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep. 23:1625–1633. 2010.PubMed/NCBI
24	Ferrara N: VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2:795–803. 2002. View Article : Google Scholar : PubMed/NCBI
25	Takahashi S: Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy. Biol Pharm Bull. 34:1785–1788. 2011. View Article : Google Scholar : PubMed/NCBI
26	Omuro AM, Faivre S and Raymond E: Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther. 6:1909–1919. 2007. View Article : Google Scholar : PubMed/NCBI
27	Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, Hankinson SE, Hutchinson A, Wang Z, Yu K, et al: A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11. 2 and 14q24. 1 (RAD51L1). Nat Genet. 41:579–584. 2009. View Article : Google Scholar : PubMed/NCBI
28	Goldstein DB: Common genetic variation and human traits. N Engl J Med. 360:1696–1698. 2009. View Article : Google Scholar : PubMed/NCBI
29	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
30	Chen K and Rajewsky N: Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet. 38:1452–1456. 2006. View Article : Google Scholar : PubMed/NCBI
31	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
32	Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
33	Duan R, Pak C and Jin P: Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 16:1124–1131. 2007. View Article : Google Scholar : PubMed/NCBI
34	Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, et al: Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science. 310:317–320. 2005. View Article : Google Scholar : PubMed/NCBI
35	Landi D, Gemignani F, Barale R and Landi S: A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol. 27:35–43. 2008. View Article : Google Scholar : PubMed/NCBI
36	He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USAmerica. 102:19075–19080. 2005. View Article : Google Scholar
37	Domigan CK, Warren CM, Antanesian V, Happel K, Ziyad S, Lee S, Krall A, Duan L, Torres-Collado AX, Castellani LW, et al: Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy. J Cell Sci. 128:2236–2248. 2015. View Article : Google Scholar : PubMed/NCBI